FdaApplication
ANDA 209599
Identifiers
- fda_app_no: ANDA209599
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING |
| application_type | ANDA |
| approval_date | 2020-11-12 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CHOLESTYRAMINE LIGHT | CHOLESTYRAMINE | EQ 4GM RESIN/PACKET | POWDER;ORAL |
| CHOLESTYRAMINE LIGHT | CHOLESTYRAMINE | EQ 4GM RESIN/SCOOPFUL | POWDER;ORAL |
2 products